A Study of Mavacamten in Obstructive Hypertrophic Cardiomyopathy

NCT05414175 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Cardiomyopathy, Hypertrophic Obstructive

Interventions

DRUG: Mavacamten

Sponsor

Bristol-Myers Squibb